Improve walking using resistance training
- Trial ID
- NCT07378813
- Official Title
- Comparison of Changes in Neuromuscular and Functional Performance Due to Resistance Training With Low-Load or High-Load in Persons With Parkinson's Disease.
- Goal
- Improve walking using resistance training
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Miami
- Study Type
- INTERVENTIONAL
- Enrollment
- 60 participants
- Conditions
- Activity, Motor
- Interventions
- Low-Load Resistance Training, High-Load Resistance Training
Plain-Language Summary
The goal is to find whether low-load or high-load resistance training better improves muscle strength, power, and everyday mobility in people with early to mid-stage Parkinson's. Participants will follow supervised weight programs using either lighter weights with higher reps to build muscle endurance and motor control, or heavier weights with lower reps to build strength and power, with the idea that stronger leg and core muscles can improve gait, balance, and transfers. The program is done alongside usual medical care, so it does not replace medications like levodopa and may help medications work better by improving overall movement and functional reserve. They plan to enroll 60 people aged 50 to 85 with Parkinson's at Hoehn and Yahr stages 1 to 3 who can walk 50 meters unassisted and have a MoCA above 18, excluding those with uncontrolled cardiovascular or neuromuscular disease, systemic inflammatory or autoimmune conditions, or unresolved limb injuries that prevent weight training.
Locations
- Laboratory of Neruomuscular Research and Active Aging, Coral Gables, Florida, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Low-Load Resistance Training. The goal is to find whether low-load or high-load resistance training better improves muscle strength, power, and everyday mobility in people with early to mid-stage Parkinson's. Participants will follow supervised weight programs using either lighter weights with higher reps to build muscle endurance and motor control, or heavier weights with lower reps to build strength and power, with the idea that stronger leg and core muscles can improve gait, balance, and transfers. The program is done alongside usual medical care, so it does not replace medications like levodopa and may help medications work better by improving overall movement and functional reserve. They plan to enroll 60 people aged 50 to 85 with Parkinson's at Hoehn and Yahr stages 1 to 3 who can walk 50 meters unassisted and have a MoCA above 18, excluding those with uncontrolled cardiovascular or neuromuscular disease, systemic inflammatory or autoimmune conditions, or unresolved limb injuries that prevent weight training.
- Who can participate?
- Participants must be between 50 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 4 months.